NCT03384355

Brief Summary

In this prospective, observational study, the investigators aim to investigate the symptoms of varicose vein patients.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
3,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2018

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 18, 2017

Completed
9 days until next milestone

First Posted

Study publicly available on registry

December 27, 2017

Completed
5 days until next milestone

Study Start

First participant enrolled

January 1, 2018

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

December 27, 2017

Status Verified

December 1, 2017

Enrollment Period

11 months

First QC Date

December 18, 2017

Last Update Submit

December 24, 2017

Conditions

Keywords

varicose veinschronic venous diseaseecchymosissymptoms

Outcome Measures

Primary Outcomes (1)

  • Venous Insufficiency Epidemiological and Economic Study- Symptom score evaluation

    Venous Insufficiency Epidemiological and Economic Study-Quality of Life/Symptoms (VEINES-QoL/Sym) questionnaire is a patient based, designed for self-completion instrument to measure both the symptom severity and quality of life. VEINES-QOL measures life quality and VEINES-Sym provides an overall estimate of CVD symptom frequency. Lower VEINES-Sym scores indicate more severe symptoms and higher VEINES-QoL/Sym scores indicate better QoL.VEINES-Sym consists of ten items including nine venous symptoms (heavy legs, aching legs, swelling, night cramps, heat/burning sensation, restless legs, throbbing, itching and tingling sensation) in five different frequencies (1=everyday, 2= several times a week, 3= about once a week, 4= less than once a week, 5= never) and leg pain rated on a six-point scale of intensity (1 = very severe, 2= severe, 3 =moderate, 4 = mild, 5 =very mild, 6= none).

    baseline

Secondary Outcomes (2)

  • Evaluation of additional symptoms

    baseline

  • CEAP (clinical, etiological, anatomical and pathological) clinical classification

    baseline

Study Arms (7)

Class 0

no visible or palpable varicose veins

Class 1

telengiectasia ( thread veins, spider veins, broken veins)

Class 2

varicose veins

Class 3

edema

Class 4

skin changes (pigmentation, eczema, lipodermatosclerosis, atrophie blanche)

Class 5

healed venous ulcer

Class 6

active venous ulcer

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients admitting to cardiology and/or cardiovascular surgery outpatient clinics and do not match the exclusion criteria

You may qualify if:

  • aged between 18-75 years

You may not qualify if:

  • \< 18 year old
  • \> 75 year old
  • malignancy
  • active infection
  • hematological disease (severe anemia, leukemia, polistemia vera, sickle cell disease)
  • collagen tissue disease
  • severe decompensated heart failure (ejection fraction \< 40%)
  • cor pulmonale
  • rheumatoid arthritis
  • degenerative arthritis
  • history of lower extremity orthopedic surgery
  • lombar disk hernia
  • history of coronary artery by-pass surgery
  • severe psychiatric and neurological disease (parkinson disease, schizophrenia, bipolar disease, alzheimer disease, etc.)
  • peripheral arterial disease ( history of interventional procedure, claudication, active ischemic complaints)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (7)

  • Ozturk S, Yetkin E. Identifying symptoms in chronic venous diseases. Eur J Obstet Gynecol Reprod Biol. 2016 Aug;203:331. doi: 10.1016/j.ejogrb.2016.04.011. Epub 2016 Jun 23. No abstract available.

  • Yetkin E, Ileri M. Dilating venous disease: Pathophysiology and a systematic aspect to different vascular territories. Med Hypotheses. 2016 Jun;91:73-76. doi: 10.1016/j.mehy.2016.04.016. Epub 2016 Apr 11.

  • Yetkin E. Hemorrhoid, internal iliac vein reflux and peripheral varicose vein: Affecting each other or affected vessels? Phlebology. 2015 Mar;30(2):145. doi: 10.1177/0268355514565196. Epub 2014 Dec 19. No abstract available.

  • Yetkin E, Öztürk S and Ileri M. Varicose Vein And Ecchymosis: A Case Report. International Archives of Medicine. 2017; 10.

    RESULT
  • Yetkin E. Complexity of venous symptoms. Phlebology. 2016 Mar;31(2):147. doi: 10.1177/0268355515574152. Epub 2015 Feb 19. No abstract available.

  • Yetkin E. Images in Vascular Medicine. A new or overlooked finding of varicose veins: Ecchymosis. Vasc Med. 2016 Feb;21(1):75-6. doi: 10.1177/1358863X15607654. Epub 2015 Oct 5. No abstract available.

  • Yetkin E, Ileri M, Waltenberger J. Ecchymosis: A novel sign in patients with varicose veins. Clin Hemorheol Microcirc. 2018;68(4):413-419. doi: 10.3233/CH-170320.

MeSH Terms

Conditions

Varicose VeinsPathological Conditions, Signs and SymptomsEcchymosis

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesBlood Coagulation DisordersHematologic DiseasesHemic and Lymphatic DiseasesHemorrhagePathologic ProcessesSkin ManifestationsSigns and Symptoms

Study Officials

  • Mehmet Ileri, MD

    Ankara City Hospital Bilkent

    STUDY CHAIR

Central Study Contacts

Ertan Yetkin, Professor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 18, 2017

First Posted

December 27, 2017

Study Start

January 1, 2018

Primary Completion

December 1, 2018

Study Completion

December 1, 2018

Last Updated

December 27, 2017

Record last verified: 2017-12